Ampullary carcinoma: an overview of a rare entity and discussion of current and future therapeutic challenges

A Rizzo, V Dadduzio, L Lombardi, AD Ricci… - Current …, 2021 - mdpi.com
Ampullary carcinomas (ACs) represent a rare entity, accounting for approximately 0.2% of all
gastrointestinal solid tumors and 20% of all periampullary cancers (PACs). Unfortunately …

[HTML][HTML] Ampulla of Vater carcinoma: Molecular landscape and clinical implications

A Pea, G Riva, R Bernasconi, E Sereni… - World journal of …, 2018 - ncbi.nlm.nih.gov
Ampulla of Vater is a peculiar anatomical structure, characterized by the crossroad of three
distinct epithelia: Intestinal, ductal pancreatic and biliary. Adenocarcinomas arising in this …

[HTML][HTML] Review of the investigation and surgical management of resectable ampullary adenocarcinoma

J Askew, S Connor - Hpb, 2013 - Elsevier
Background Ampullary adenocarcinoma is considered to have a better prognosis than either
pancreatic or bile duct adenocarcinoma. Pancreaticoduodenectomy is associated with …

Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy

MD Chandrasegaram, SC Chiam, JW Chen… - World journal of surgical …, 2015 - Springer
Background Pancreatic cancer (PC) has the worst survival of all periampullary cancers. This
may relate to histopathological differences between pancreatic cancers and other …

[HTML][HTML] Establishment and characterization of a new human ampullary carcinoma cell line, DPC-X1

H Xu, CP Chai, X Miao, H Tang, JJ Hu… - World Journal of …, 2023 - ncbi.nlm.nih.gov
BACKGROUND An in-depth study of the pathogenesis and biological characteristics of
ampullary carcinoma is necessary to identify appropriate treatment strategies. To date, only …

The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinoma

TN Showalter, T Zhan, PR Anne, I Chervoneva… - Journal of …, 2011 - Springer
Introduction The prognosis after pancreaticoduodenectomy (PD) for ampullary carcinoma
(AC) is superior to that of pancreatic cancer. Decisions regarding adjuvant therapy are …

[HTML][HTML] Impact of sarcopenia in borderline resectable and locally advanced pancreatic cancer patients receiving stereotactic body radiation therapy

WH Jin, EA Mellon, JM Frakes… - Journal of …, 2018 - ncbi.nlm.nih.gov
Background Total psoas area (TPA), a marker of sarcopenia, has been used as an
independent predictor of clinical outcomes in gastrointestinal (GI) cancers as a proxy for …

Establishment and characterization of a new intestinal-type ampullary carcinoma cell line, DPC-X3

C Chai, X Miao, Y Su, C Yu, H Tang, L Li, Z Wang, J Yi… - BMC cancer, 2024 - Springer
Ampullary carcinoma (AC) of the intestinal type represents a distinct variant within the
broader category of ampullary neoplasms. The scarcity of pertinent cellular models has …

Ampullary carcinoma of the duodenum: current clinical issues and genomic overview

K Okano, M Oshima, H Suto, Y Ando, E Asano… - Surgery Today, 2021 - Springer
Ampullary carcinomas of the duodenum are uncommon. Moreover, the diversity in the
clinical outcomes of these patients makes it difficult to interpret previous studies and clinical …

[HTML][HTML] Prognostic factors and benefits of adjuvant therapy for ampullary cancer following pancreatoduodenectomy: a systematic review and meta-analysis

YM Zhou, S Liao, YZ Wei, SJ Wang - Asian Journal of Surgery, 2020 - Elsevier
Ampullary cancer is a relatively rare gastrointestinal malignancy. The purpose of this study
was to evaluate prognostic factors for survival and assess the benefits of adjuvant therapy …